Cell research on rare disease finds new link to inflammation
"How many people actually have this disease?"
Feb 28, 2022
0
71
"How many people actually have this disease?"
Feb 28, 2022
0
71
By adapting computer models originally developed to understand the biology of cancer cells, UCL scientists have identified new drug combinations with the potential to treat severe cases of COVID-19 infection at different ...
Feb 16, 2022
0
8
COVID-19 is the disease caused by infection with the SARS-CoV-2 virus. Since it emerged at the end of 2019, the virus has caused a global pandemic. Vaccination against COVID-19 has brought hope, but has also raised questions. ...
Feb 9, 2022
0
0
In adults who had previously received a full regimen of any of three COVID-19 vaccines granted Emergency Use Authorization (EUA) or approved by the Food and Drug Administration (FDA), an additional booster dose of any of ...
Jan 26, 2022
0
139
A research team led by Prof. Stephan Ludwig, a virologist at the Institute of Virology at the University of Münster, has found a new dual attack mode of action while working on the development of a drug candidate against ...
Jan 14, 2022
0
201
An international team of scientists has created a plan for an accelerated pipeline for developing drug cocktails to battle the COVID-19 pandemic. The pipeline could speed new and better treatments that the newly diagnosed ...
Dec 21, 2021
0
18
Researchers in Japan and the United States have found SARS-CoV-2 can knock out an important molecular pathway linked to an immune complex called MHC class I. The finding should help scientists better understand how COVID-19 ...
Dec 7, 2021
1
174
A metabolic enzyme that has been studied in cancer biology and is important for T cell function may offer a new target for anti-inflammatory therapeutics, Vanderbilt researchers have discovered. They report Nov. 11 in the ...
Nov 11, 2021
0
51
An experimental drug enhanced the benefit of an immunotherapy to fight pancreatic cancer in mice by increasing the number of immune cells in the immediate vicinity of the tumor, leading to a reduction in tumor growth, and ...
Nov 4, 2021
0
112
A new study led by Yale Cancer Center researchers shows that the enzyme KDM5B suppresses anti-melanoma immunity. These findings could help develop a new treatment strategy to benefit patients with melanoma and other cancers, ...
Oct 20, 2021
0
129